Compare Bristol-Myers Squibb Co (BMY) vs Danaos Corporation (DAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Danaos Corporation — how do they compare? Bristol-Myers Squibb Co trades at $63.61 (market cap $129.94B), while Danaos Corporation trades at $135.01 (market cap $2.46B). The key difference: Bristol-Myers Squibb Co is far larger — about 52.8× Danaos Corporation's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | DAC | |
|---|---|---|
Market Cap | $129.94B | $2.46B |
Sector | Health | Technology |
52-Week High | $65.89 | $143.15 |
52-Week Low | $42.60 | $84.05 |
Enterprise Value | $163.92B | $2.44B |
Dividend Yield | 3.96% | 2.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →
